Q-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes
17.6
SEK-2.22
percentQ-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes
17.6
SEK-2.22
percentFuture-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
Press releases
Q-linea awarded a contract position with Premier, Inc.
Q-linea Announces ASTar® Contract With Large Health System in the U.S. Mid-Atlantic Region
Interim report January 1 – June 30 2026
FDA decision sets up for growth in U.S. FDA clearance for expanded U.S. menu combined with encouraging progress across…
Read more >
Keep up to date – subscribe
.
.
.